FDA Approves First Generic Once-Weekly Hormone Therapy Patch
The FDA approved the first generic of Climara Pro, an estradiol and levonorgestrel transdermal hormone therapy patch applied once weekly.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The FDA approved the first generic of Climara Pro, an estradiol and levonorgestrel transdermal hormone therapy patch applied once weekly.